New treatment combination may improve outcomes for children with rare cancers
Children who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain anti-tumour drugs as well as chemotherapy, a new trial has found.
The r…
Professor Amos Burke appointed Director of Birmingham’s Cancer Research UK Clinical Trials Unit (CRCTU)
Professor Amos Burke has been appointed as the new Director of the Cancer Research UK Clinical Trials Unit, based at BHP founder-member the University of Birmingham.
Professor Burke – a paediatric…
Epilepsy in pregnancy – new project to create personalised care for at-risk mums
Pregnant women with epilepsy could see a major improvement in the care they receive through a new cross-BHP project led by the University of Birmingham with Birmingham Women’s and Children’s Hospital…
Eye-safe laser technology to diagnose traumatic brain injury
Researchers from BHP founder-member the University of Birmingham have designed and developed a novel diagnostic device designed for the early detection of traumatic brain injury (TBI), whic…
Rare disease trials to develop playbook for testing new treatments
Patients with rare diseases could benefit from a ‘revolution’ in clinical trials that could see one-stop studies designed to provide robust results even with small numbers of participants.
The CAP…
Giving progesterone in early pregnancy may reduce preeclampsia risk – preliminary study
Prescribing vaginal progesterone treatment early in pregnancy appears to reduce risk of developing preeclampsia – a potentially fatal condition – by approximately 39%, a recent research review sugges…